Eli Lilly secures Alimta patent win over Apotex

02-01-2020

Rory O'Neill

Eli Lilly secures Alimta patent win over Apotex

Jonathan Weiss / Shutterstock.com

Eli Lilly has won a victory in a cancer drug dispute after a federal judge ruled that Canadian pharmaceutical company Apotex’s new drug application (NDA) infringed the company’s patent.


Alimta, Apotex, Eli Lilly, cancer, new drug application, US Patent and Trademark Office

More on this story

Intercept sues Apotex over Ocaliva generic
26-08-2020

LSIPR